Long-term Study of FK949E in Elderly Bipolar Disorder Patients
NCT01737268
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorder
Elderly
Interventions
DRUG:
FK949E
Sponsor
Astellas Pharma Inc